UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 288

Sortiert nach

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

Respiratory research, 2014-10, Vol.15 (1), p.123-123, Article 123

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma

American journal of respiratory and critical care medicine, 2013-12, Vol.188 (11), p.1294-1302

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

Respiratory research, 2019-10, Vol.20 (1), p.238-15, Article 238

2019

Link zum Volltext

Verfügbarkeit prüfen

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective

Respiratory research, 2019-07, Vol.20 (1), p.141-141, Article 141

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.339-345

2013

Link zum Volltext

Verfügbarkeit prüfen

Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone

Respiratory medicine, 2019-05, Vol.151, p.35-42

2019

Link zum Volltext

Verfügbarkeit prüfen

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

Respiratory research, 2019-07, Vol.20 (1), p.167-167, Article 167

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

The Journal of infectious diseases, 2023-03, Vol.227 (6), p.761-772

2023

Link zum Volltext

Verfügbarkeit prüfen

A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD

Respiratory medicine, 2013-04, Vol.107 (4), p.560-569

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials

The lancet respiratory medicine, 2014-06, Vol.2 (6), p.472-486

2014

Link zum Volltext

Verfügbarkeit prüfen

Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study

The European respiratory journal, 2018-09, Vol.52 (3), p.1801334

2018

Link zum Volltext

Verfügbarkeit prüfen

Long term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease

Respiratory medicine, 2017-05, Vol.126, p.105-115

2017

Link zum Volltext

Verfügbarkeit prüfen

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

Nature medicine, 2022-04, Vol.28 (4), p.823-830

2022

Link zum Volltext

Verfügbarkeit prüfen

Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials

Clinical drug investigation, 2021-06, Vol.41 (6), p.579-590

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

Respiratory research, 2021-10, Vol.22 (1), p.279-279, Article 279

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD

Respiratory research, 2018-03, Vol.19 (1), p.38-38, Article 38

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD

Pulmonary pharmacology & therapeutics, 2020-02, Vol.60, p.101873, Article 101873

2020

Link zum Volltext

Verfügbarkeit prüfen

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

Respiratory medicine, 2011-05, Vol.105 (5), p.719-726

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)

Chronic obstructive pulmonary disease, 2012-04, Vol.9 (2), p.90-101

2012

Link zum Volltext

Verfügbarkeit prüfen

Improvement Of Lung Function As Early As Day 1 With Beclomethasone Dipropionate Breath-Actuated Inhaler In Patients With Persistent Asthma

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB214-AB214

2018

Link zum Volltext

Verfügbarkeit prüfen

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease

Respiratory research, 2017-11, Vol.18 (1), p.182-182, Article 182

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.1225-1243

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids

The Journal of asthma, 2017-01, Vol.54 (1), p.89-98

2017

Link zum Volltext

Verfügbarkeit prüfen

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.1137-1148

2021

Link zum Volltext

Verfügbarkeit prüfen

Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD

Respiratory medicine, 2022-08, Vol.200, p.106918-106918, Article 106918

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(253)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(288)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Life Sciences & Biomedicine
(174)
Humans
(144)
Female
(106)
Male
(102)
Respiratory System
(88)
Middle Aged
(81)
Aged
(76)
Double-Blind Method
(60)
Chronic Obstructive Pulmonary Disease
(57)
Adult
(56)
Treatment Outcome
(55)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(51)
Administration, Inhalation
(49)
Bronchodilator Agents - Administration & Dosage
(40)
Copd
(40)
Asthma
(35)
Pulmonary/respiratory
(35)
Drug Therapy
(32)
Patients
(32)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients

Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials

Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study

Long term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD

Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)

Improvement Of Lung Function As Early As Day 1 With Beclomethasone Dipropionate Breath-Actuated Inhaler In Patients With Persistent Asthma

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy

Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD

Suchergebnisse filtern